Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Post Market Surveillance & Vigilance

We're PMS and Vigilance Ready. Are you?

2018 Highlights Include:

Overcome your PMS & vigilance obstacles
  • How are different companies practically implementing new requirements?
  • Immerse yourself in PMS plan compilation
  • Timelines for post market reporting are changing: Can you keep up?
  • Ensure a best practice approach for Field Safety Corrective Action (FSCA) reporting
  • Leverage your PMS data to become better informed about your products
Competent Authority, Notified Body and industry perspectives from:
  • National Institute for Public Health and the Environment (RIVM)
  • TÜV SÜD Product Service
  • Cendres + Métaux SA
  • Medtronic
  • Terumo Europe N.V.
Sharing experiences and strategies

We’ll be hosting interactive panel discussions on:

  • How are different companies implementing new PMS and vigilance requirements?
  • How can I be compliant with the EU MDR post market activities and reports?

Free On-Demand Content

Webinars. Webinars. Webinars.

EU MDR Labeling Compliance: Learn the Lessons from UDI

Mark Cusworth, VP Research and Development, PRISYM ID
Andrew Love, VP Capability Development, Be4ward

Latest status and practical experience of implementing the new EU MDR

Bassil Akra, Vice President, Global Focus Teams (Cardiovascular, Orthopeadic and Clinical), TÜV SÜD Product Service GmbH, Germany